Search Orphan Drug Designations and Approvals
-
Generic Name: | macitentan |
---|---|
Date Designated: | 06/15/2017 |
Orphan Designation: | Treatment of chronic thromboembolic pulmonary hypertension (CTEPH) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Actelion Clinical Research, Inc. 1820 Chapel Avenue West Suite 300 Cherry Hill, New Jersey 08002 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-